# US 2004/0081671 A1 · Liquid dosage forms of non-enterically coated acid-labile drugs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0081671 A1
- Document ID: US20040081671A1
- Status: Published application
- Kind: A1
- Application number: 10/611,582
- Filed: 2003-07-01
- Published: 2004-04-29
- Earliest claimed: 2002-07-03
- Inventors: Rajneesh Taneja
- Web page: https://patentgrep.com/patent/US20040081671A1

## CPC

- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided herein are formulations of acid labile drugs, such as proton pump inhibitors (PPI). The formulations comprise a PPI and a liquid vehicle typically having a pH greater than 6.5 and a viscosity sufficient to maintain a uniform suspension of the PPI for 15 minutes.

## Claims

### Claim 1

A composition comprising:
(a) a PPI; and
(b) a liquid vehicle having a pH greater than 6.5 and a viscosity sufficient to maintain a uniform suspension of the PPI.

### Claim 2 (depends on 1)

The composition of claim 1 wherein the liquid vehicle comprises a metal salt buffer.

### Claim 3 (depends on 1)

The composition of claim 1 wherein the proton pump inhibitor is lansoprazole.

### Claim 4 (depends on 1)

The composition of claim 1 wherein the composition has at least 2 doses of the PPI.

### Claim 5 (depends on 1)

The composition of claim 1 wherein the viscosity of the composition is greater than 50 cp.

### Claim 6 (depends on 1)

The composition of claim 1 wherein the viscosity of the composition is greater than 70 cp.

### Claim 7

A method of treating a patient with a gastrointestinal disorder comprising providing to the patient a composition comprising a PPI and a liquid vehicle having a pH greater than 6.5 and a viscosity sufficient to maintain a uniform suspension of the PPI.

### Claim 8

A kit comprising:
(a) a first container having dry ingredients including a PPI; and
(b) a second container having liquid ingredients;
wherein when said first and second container are combined they provide a formulation comprising a PPI and a liquid vehicle having a pH greater than 6.5 and a viscosity sufficient to maintain a uniform suspesion of the PPI for 15 minutes.
